title: Dobutamine for patients with end-stage heart failure in a hospice program?
authors.affiliation: Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA. mrich@im.wustl.edu
authors.forename: Michael W
authors.initials: MW
authors.lastname: Rich
authors.forename: Bernard L
authors.initials: BL
authors.lastname: Shore
mesh_terms: D000368:Aged; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004280:Dobutamine / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D017051:Hospice Care; D006801:Humans; D008297:Male; D010166:Palliative Care; D016896:Treatment Outcome; D014481:United States
chemical_list: D002316:Cardiotonic Agents; D004280:Dobutamine